Lillys

Eli Lilly’s Challenge Fails as $183.7 Million Medicaid Fraud Penalty Stands Firm

by

Indianapolis, Indiana – Eli Lilly and Company has faced a setback in its legal challenges after a federal appeals court upheld a substantial judgment concerning Medicaid fraud. The ruling confirms a $183.7 million award against the pharmaceutical giant, which has been embroiled in allegations related to the pricing of its medications. The Court of Appeals for the Seventh Circuit denied Lilly’s request to overturn the previous decision made by a lower court, emphasizing the severity of the company’s actions in relation to Medicaid. The case centered around claims that Eli Lilly knowingly set prices for … Read more

Federal Judge Upholds Ban on Generic Versions of Lilly’s Breakthrough Weight Loss Medication

by

Indianapolis — A federal judge in Indiana has refused to issue an injunction that would have halted a ban on unauthorized copies of a widely popular weight-loss medication produced by Eli Lilly and Company. This decision keeps in place the enforcement against the manufacturing and distribution of generic versions of the pharmaceutical giant’s patented drug. This ruling directly impacts a number of pharmaceutical manufacturers who have been accused by Eli Lilly of infringing on its patents by replicating Mounjaro, a drug which has shown significant efficacy in both weight management and the treatment of type … Read more